Diagnos Inc — AGM Information 2023

Sep 8, 2023

DIAGNOS INC.

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN that the annual general meeting of shareholders (the “Meeting”) of DIAGNOS Inc. (the “Corporation”) will be held on September 28, 2023, at 10:00 a.m., by virtual means or in person (please refer to instructions on page ii), for the following purposes:

1. To receive the annual report of management, the audited consolidated financial statements of the Corporation for the financial year ended March 31, 2023 and the independent auditor’s report thereon;

2. To elect the directors of the Corporation;

3. To reappoint Raymond Chabot Grant Thornton, LLP, as independent auditor of the Corporation for the ensuing year and to authorize the directors to fix its remuneration; and

4. To transact such other business as may properly come before the Meeting or any adjournment thereof.

The Form of Proxy and the Management information circular accompany this notice. For the shareholders who expressively requested such documents, the annual management report and the audited consolidated financial statements of the Corporation for the financial year ended March 31, 2023 also accompany this notice.

DATED at Brossard, Quebec, this 24[th] day of August 2023.

By order of the Board of Directors

(s) Marc-André Massue

Marc-André Massue Vice-President Finance and Corporate Secretary DIAGNOS Inc.

i

DIAGNOS INC.

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

� Instructions for attendance / participation at the Meeting:

Registered shareholders and Non-Registered Holders who do not intend to vote at the Meeting are - - kindly asked to participate via videoconferencing using this link: https://meet.google.com/cbh vyur hvk. If you need assistance, please phone (450) 678-8882, extension 235, at least ten (10) minutes before the start of the Meeting.

As remote participants will not be able to vote at the Meeting, only registered shareholders and duly appointed proxyholders who intend to vote at the Meeting will be able to attend the Meeting in person at the Corporation’s head office located at 7005 Taschereau Blvd, Suite 265, Brossard, QC, J4Z 1A7.

� If you are unable to attend the Meeting in person, please complete, date and sign the enclosed Form of Proxy and return it in the envelope provided for that purpose.

ii